Medical Marijuana – Consumers’ Perspectives in the US and UK

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData’s Medical Marijuana, Consumers’ Perspectives report combines an extensive survey and analysis of patients’ perspectives in the US and UK to provide an in-depth consumer-centered review of the medical marijuana market. Components of the report include an in-depth breakdown of the survey and its respondents, detailed analysis of consumers’ concerns and opinions of medical and recreational marijuana, information from interviews with patients receiving treatment with medical marijuana in the US and UK, and an assessment of the impact of the COVID-19 pandemic on the medical marijuana space. The report evaluates trends across different age groups, health statuses, and other parameters to inform insightful comparisons and market-specific analyses, always linking the significance of the findings to the historical and contemporary events underpinning consumers’ perspectives in the two countries on which this thematic research focuses on.

Scope

The report provides an overview of the design of the study, including a breakdown of the respondents from each of the markets. Other components include the analysis of key perspectives, broken down into different age groups and presence or absence of chronic illness, a discussion of the unmet needs, legal restrictions on medical marijuana, evaluation of the scientific evidence to support the use of medical marijuana, and an assessment of the potential impact of COVID-19 on the medical marijuana space. In the report, there is also analysis of key concerns of consumers in the US and UK and a discussion of the findings from interviews with consumers who personally benefit from receiving treatment with medical marijuana. In addition, there is an examination of the stigmatization of marijuana users and an overview of social issues regarding the perception of recreational marijuana.

Key Highlights

• The majority (72%) of respondents stated that one of their greatest concerns with regards to receiving treatment with medical marijuana therapies was the potential for psychological side effects and cognitive impairment.

• More respondents from the UK (34%) than respondents from the US (25%) were in favor of legalizing recreational marijuana. Differently, 91% of respondents from the US and 87% of respondents from the UK were in favor of legalizing marijuana for medicinal purposes.

• Many respondents from both markets expressed feelings of uncertainty about the law regarding the use of medical marijuana. This was mainly due to the dynamic regulatory landscape in which restrictions are repeatedly altered with little attention drawn to these modifications.

• Although the use of medical marijuana is well documented for some indications such as pain, muscle spasticity, and epilepsy, many sufferers of other conditions remain unsure about its efficacy for other diseases, despite the active clinical trials landscape.

• Increased media coverage and attention on medical marijuana is attracting a wide audience.

• The reputation of marijuana is changing alongside the emergence of results from clinical studies that aim to prove that the applications in medicine may be more widespread than what was previously believed.

• According to GlobalData’s primary research, the COVID-19 pandemic and lockdown measures are already changing operations within the medical marijuana industry.

• The ability to access medical marijuana differs across state borders in the US, and constituencies in the UK, and these discrepancies are expected to increase further against the backdrop of the COVID-19 pandemic.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies with consumers’ perspectives in mind in order to gain an insight into the methods to develop products with the greatest chance of success in the medical marijuana environment.

• Identify potential agreements, partnerships, licensing or M&A opportunities in line with the strategies most likely to provide appropriate solutions for issues raised by underserved patients in the medical marijuana space.

• Examine consumers’ perspectives on various aspects of treatment with respect to medical marijuana therapies.

• Develop business strategies by understanding the trends shaping and driving the medical marijuana space from consumers’ perspectives.

• Drive revenues by understanding the key trends in consumer sentiments and what actions need to be taken to companies who wish to gain a foothold in the medical marijuana environment.

• Formulate effective sales and marketing strategies by understanding the medical marijuana landscape and identify the unmet needs for patients in this therapy area.

• Examine the impact of COVID-19 on the medical marijuana space and devise strategies to minimize the effects of the pandemic on businesses and patients alike.

• Organize your sales and marketing efforts by identifying the consumers that are most likely to have a vested interest in medical marijuana, allowing your company to capitalize on opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Table of Contents

1. Study Design

1.1 Research Objectives and Study Design

1.2 Respondent Mix – Geography

1.3 Respondent Mix – Age, Sex, and Disease Status

1.4 Respondents With Chronic Illness

2. Executive Summary

2.1 Key Findings

3. Survey Respondents by Market

3.1 Respondents in the US

3.2 Respondents in the US With Chronic Illness

3.3 Respondents in the UK

3.4 Respondents in the UK With Chronic Illness

4. Consumers’ Perspectives

4.1 Overview of Perspectives in the US and UK

4.2 Unmet Needs

4.3 Consumer Insights

5. Consumers in the US

5.1 Take-Home Messages

5.2 Consumer Insights

6. Consumers in the UK

6.1 Take-Home Messages

6.2 Consumer Insights

7. Medical Marijuana and COVID-19

7.1 The Impact of the Pandemic on the Medical Marijuana Industry

7.2 Patients’ Perspectives

8. Patients’ Insights

8.1 Insights From the US

8.2 Insights From the UK

9. Summary of Key Findings

9.1 Take-Home Messages

10. Appendix

10.1 Related Reports

10.2 Primary Research – Interviewees

10.3 About the Authors

10.4 About Thematic Research

10.5 About GlobalData

10.6 Contact Us

10.7 Disclaimer

Frequently asked questions

Medical Marijuana – Consumers’ Perspectives in the US and UK thematic reports
Currency USD
$695

Can be used by individual purchaser only

$1,495

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Medical Marijuana – Consumers’ Perspectives in the US and UK was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Medical Marijuana – Consumers’ Perspectives in the US and UK in real time.

  • Access a live Medical Marijuana – Consumers’ Perspectives in the US and UK dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.